Kovacs Shane William Charles 4
4 · Olema Pharmaceuticals, Inc. · Filed Jan 16, 2024
Insider Transaction Report
Form 4
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
Transactions
- Exercise/Conversion
Common Stock
2024-01-12$7.02/sh+50,000$351,000→ 484,987 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-01-12−50,000→ 187,000 totalExercise: $7.02Exp: 2032-01-31→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.